Search

Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia

Publication: Bill

Bechis, S. K., A. G. Otsetov, R. Ge, Z. Wang, M. G. Vangel, C. L. Wu, S. Tabatabaei, and A. F. Olumi. 2015. Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia.

Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma

Publication: Bill

Cornejo, K. M., M. Lu, P. Yang, S. Wu, C. Cai, W. D. Zhong, A. Olumi, R. H. Young, and C. L. Wu. 2015. Succinate Dehydrogenase B: A New Prognostic Biomarker in Clear Cell Renal Cell Carcinoma.

PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53

Publication: Bill

Liu, Q., L. Gheorghiu, M. Drumm, R. Clayman, A. Eidelman, M. F. Wszolek, A. Olumi, et al. 2018. PARP-1 Inhibition With or Without Ionizing Radiation Confers Reactive Oxygen Species-Mediated Cytotoxicity Preferentially to Cancer Cells With Mutant TP53.

Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome

Publication: Bill

Wu, S., S. X. Lin, G. J. Wirth, M. Lu, J. Lu, A. O. Subtelny, Z. Wang, D. M. Dahl, A. F. Olumi, and C. L. Wu. 2019. Impact of Multifocality and Multilocation of Positive Surgical Margin After Radical Prostatectomy on Predicting Oncological Outcome.

Advancing bladder preservation: Biomarkers, decision-making, and therapy

Publication: Bill

McConkey, D., C. J. M. Best, J. A. Gumminger, and A. F. Olumi. 2021. Advancing Bladder Preservation: Biomarkers, Decision-Making, and Therapy.

The impact of pretreatment PSA on risk stratification in men with Gleason 6 prostate cancer: Implications for active surveillance

Publication: Bill

Monfared, S., A. Fleishman, R. Korets, P. Chang, A. Wagner, G. Bubley, I. Kaplan, A. F. Olumi, and B. Gershman. 2021. The Impact of Pretreatment PSA on Risk Stratification in Men With Gleason 6 Prostate Cancer: Implications for Active Surveillance.

Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladder

Publication: Bill

Bharadwaj, M., S. Kaul, A. Fleishman, R. Korets, P. Chang, A. Wagner, S. Kim, et al. 2022. Adjuvant Chemotherapy versus Observation Following Radical Cystectomy for Locally Advanced Urothelial Carcinoma of the Bladder.

Adjuvant Chemotherapy Plus Radiotherapy versus Chemotherapy Alone for Locally Advanced Bladder Cancer after Radical Cystectomy

Publication: Bill

Ernandez, J., S. Kaul, A. Fleishman, R. Korets, P. Chang, A. Wagner, S. Kim, et al. 2022. Adjuvant Chemotherapy Plus Radiotherapy versus Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy.

Single black men have the worst prognosis with localized prostate cancer

Publication: Bill

Liu, S., Z. Wang, X. Long, A. Fleishman, X. Huang, Q. Wu, B. Gershman, and A. F. Olumi. 2022. Single Black Men Have the Worst Prognosis With Localized Prostate Cancer.

Practical Use of Self-Adjusted Nitrous Oxide During Transrectal Prostate Biopsy: A Double-Blind Randomized Controlled Trial

Publication: Bill

Escobar, A. J., S. Krishna, K. M. Flowers, A. Abello, B. Gershman, A. A. Wagner, P. Chang, et al. 2024. Practical Use of Self-Adjusted Nitrous Oxide During Transrectal Prostate Biopsy: A Double-Blind Randomized Controlled Trial.

Search

Search results